HMGCR and open-angle glaucoma: In addition, cholesterol-lowering statin, an inhibitor of HMG-CoA reductase, can decrease the risk of POAG and be an effective therapy for POAG (McGwin et al., 2004; Stein et al., 2012; Wu et al., 2020).